Bank AL Habib Limited (PSX:BAHL)

Aerovate Therapeutics Income Statement

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Interest Income on Loans	451,303	478,117	373,888	200,911	116,747	125,290
Interest Income on Investments	346.88	363.5	701.54	684.36	475.44	432.36
Total Interest Income	451,650	478,480	374,589	201,595	117,223	125,723
Interest Paid on Deposits	298,315	321,647	249,743	123,592	61,268	67,649
Net Interest Income	153,335	156,834	124,846	78,003	55,955	58,074
Net Interest Income Growth (YoY)	11.69%	25.62%	60.05%	39.40%	-3.65%	39.59%
Gain (Loss) on Sale of Assets	1,037	1,015	403.78	452.29	467.55	440.31
Gain (Loss) on Sale of Investments	-322.83	142.13	30.92	138.86	-38.25	186.63
Gain (Loss) on Sale of Equity Investments	1,305	1,401	1,134	778.63	372.03	114.34
Other Non-Interest Income	27,004	25,855	22,033	19,527	13,213	9,259
Total Non-Interest Income	29,023	28,413	23,602	20,896	14,015	10,000
Non-Interest Income Growth (YoY)	15.17%	20.39%	12.95%	49.10%	40.14%	9.10%
Revenues Before Loan Losses	182,357	185,247	148,448	98,900	69,970	68,074
Provision for Loan Losses	6,860	14,891	4,100	12,881	314.48	4,425
Revenue	175,498	170,356	144,348	86,019	69,655	63,649
Revenue Growth (YoY)	16.65%	18.02%	67.81%	23.49%	9.44%	34.37%
Salaries and Employee Benefits	1,766	1,761	1,561	821.63	623.62	673.05
Selling, General & Administrative	6,562	5,840	6,129	3,776	3,736	3,606
Other Non-Interest Expense	78,713	76,066	64,624	48,366	35,079	30,576
Total Non-Interest Expense	87,041	83,667	72,315	52,964	39,438	34,855
EBT Excluding Unusual Items	88,457	86,689	72,033	33,055	30,217	28,794
Asset Writedown	-	-	-75.89	-	-	-122.19
Other Unusual Items	95.12	91.28	49.88	-	-	37.73
Pretax Income	88,552	86,780	72,007	33,055	30,217	28,709
Income Tax Expense	46,164	44,863	36,077	16,369	11,620	10,752
Earnings From Continuing Operations	42,388	41,917	35,930	16,686	18,597	17,957
Minority Interest in Earnings	-17.66	-15.63	-2.27	1.62	-13.67	-9.73
Net Income	42,371	41,902	35,928	16,688	18,583	17,948
Net Income to Common	42,371	41,902	35,928	16,688	18,583	17,948
Net Income Growth	19.18%	16.63%	115.29%	-10.20%	3.54%	60.31%
Basic Shares Outstanding	1,111	1,111	1,111	1,111	1,111	1,111
Diluted Shares Outstanding	1,111	1,111	1,111	1,111	1,111	1,111
EPS (Basic)	38.12	37.70	32.33	15.01	16.72	16.15
EPS (Diluted)	38.12	37.70	32.33	15.01	16.72	16.15
EPS Growth	19.16%	16.63%	115.29%	-10.20%	3.54%	60.31%
Dividend Per Share	17.000	17.000	14.000	7.000	7.000	4.500
Dividend Growth	-2.86%	21.43%	100.00%	-	55.56%	28.57%
Effective Tax Rate	52.13%	51.70%	50.10%	49.52%	38.46%	37.45%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.